Elicio Therapeutics CEO Jay Venkatesan's 2023 pay jumps 60% to $2.4M
Elicio Therapeutics reports 2023 executive compensation
By ExecPay News
Published: September 27, 2024
Elicio Therapeutics reported fiscal year 2023 executive compensation information on September 27, 2024.
In 2023, five executives at Elicio Therapeutics received on average a compensation package of $1.2M, a 2% increase compared to previous year.
Average pay of disclosed executives at Elicio Therapeutics
Jay R. Venkatesan, Chief Executive Officer, received $2.4M in total, which increased by 60% compared to 2022.
Jennifer J. Rhodes, General Counsel, received a compensation package of $1.4M, which increased by 77% compared to previous year. 51% of the compensation package, or $703K, was in other compensation.
Brian Piekos, Chief Financial Officer, earned $879K in 2023.
Robert Connelly, Chief Executive Officer, received $678K in 2023, which decreases by 46% compared to 2022.
Christopher Haqq, Chief Medical Officer, earned $674K in 2023, a 42% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on September 27, 2024.